Showing results (1481-1490 of 1,496) with videos related to

Sort By:
Pageof 150
Journal of Clinical Microbiology|April 9, 2005
Laboratory-based surveillance and molecular epidemiology of influenza virus in TaiwanShin-Ru Shih, Guang-Wu Chen, Ching-Chun Yang, et al.
Nature Communications|April 29, 2023
Virus diversity, wildlife-domestic animal circulation and potential zoonotic viruses of small mammals, pangolins and zoo animalsXinyuan Cui, Kewei Fan, Xianghui Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2004
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integraseDaria J Hazuda, Neville J Anthony, Robert P Gomez, et al.
Vaccine|February 15, 2022
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicitySonia Pérez-Rodríguez, Meiby de la Caridad Rodríguez-González, Rolando Ochoa-Azze, et al.
Pharmacological Research|October 29, 2021
Guidelines on the treatment with integrated traditional Chinese medicine and western medicine for severe coronavirus disease 2019Zhi-Yu Li, Zhi-Jun Xie, Hai-Chang Li, et al.
Med (New York, N.Y.)|August 23, 2022
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adultsMaría Eugenia Toledo-Romani, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, et al.
ACS Chemical Biology|July 5, 2021
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical StudiesYury Valdes-Balbin, Darielys Santana-Mederos, Lauren Quintero, et al.
Lancet Regional Health. Americas|September 20, 2021
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trialArturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, et al.
RSC Chemical Biology|April 1, 2022
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesiclesDarielys Santana-Mederos, Rocmira Perez-Nicado, Yanet Climent, et al.
Science (New York, N.Y.)|June 1, 2023
Phylogenomic analyses provide insights into primate evolutionYong Shao, Long Zhou, Fang Li, et al.
Pageof 150